Skip to main content
17 October 2026
15 October 2026

Danaher Partners with NVIDIA to Transform AI-Enabled Research

Danaher Corporation announced a collaboration with NVIDIA to advance autonomous science and help accelerate the pace of scientific discovery. As part of Danaher's broader effort to shape the future of AI-enabled science, the companies are working to combine Danaher's scientific instrumentation, automation technologies…

15 October 2026

PurMinds Expands Diagnostic Research Through Taiwan Healthcare Partnership

PurMinds Enterprises, Inc. announced the signing of a collaboration agreement with SpectroChip Inc. , a Taiwan-based developer of photonic-chip sensing and portable testing technologies, and Kaohsiung Municipal Siaogang Hospital, operated by Kaoh siung Medical University, to support teaching, research, and clinical va…

14 October 2026

Cognito and Rhode Island Life Science Hub Establish Brain Health Platform

The Rhode Island Life Science Hub (RILSH) and Cognito Therapeutics announced the launch of the Rhode Island Brain Health Collaboratory, the third Collaboratory in Cognito's growing national network, following collaborations with the West Virginia University Rockefeller Neuroscience Institute in 2025 and Ochsner Health…

14 October 2026

Scinai Signs Major Development and Manufacturing Agreement with US Biopharma Firm

Scinai Immunotherapeutics Ltd., a biopharmaceutical company operating a growing contract development and manufacturing organization ("CDMO") alongside an immunology-focused therapeutic development platform, announced that its wholly owned subsidiary, Scinai Biopharma Services Ltd., has entered into a definitive develo…

12 October 2026

LOTTE Biologics Partners with Alvotech on Biologics Manufacturing

LOTTE Biologics, a contract development and manufacturing (CDMO) organization, and Alvotech, a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced a long-term strategic manufacturing partnership. Under the agreement, LOTTE Biologics wi…

09 October 2026

SOPHiA GENETICS, Myriad Partner on Precision Prostate Cancer Diagnostics

SOPHiA GENETICSand Myriad Genetics, Inc. announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca. PrGIS is a novel biomarker signature designed to assess chromosomal instability associated with homologous re…

09 October 2026

Viatris to Acquire Pacira BioSciences for $1.65 Billion

Viatris Inc., a global healthcare company, and Pacira BioSciences, Inc., a leader in innovative non-opioid pain therapies,  announced that they have entered into a definitive agreement under which Viatris has agreed to acquire all of the outstanding shares of common stock of Pacira for $36.50 per share in cash, repres…

Page 1 of 42

slot gacor